CURVE THERAPEUTICS

Revolutionary intracellular screening platform enables a new generation of first-in-class drugs

Our Microcycle® platform enables direct screening for biologically active hits inside mammalian cells and creates a toolkit for hit-to-lead programmes.

CEO
Simon Kerry

WEB
CURVE THERAPEUTICS

INVESTED COMPANY
2019

DETAILS
Delta House
Enterprise Road Southampton Science Park
Southampton SO16 7NS GB

News